NorthWest Biotherapeutics Inc (NWBO)

[Tony888]

Jack-

On my Twitter I pinned Branko's valuation:
https://twitter.com/tc_trader

This current valuation is for -L approval but does not include -Direct which you will see in his summary.

His $27 valuation is current valuation. He is assuming 75% clinical success and further discounting by 50%. So, under scenario A, PPS between $36 and $72.

Market is currently valuing Juno at $5B. So, applying the same multiple, we get a pps of around $50. Conservatively, if we say market is assuming 50% clinical success for JUNO, we get a pps of $100.

On a short squeeze, pps could get north of $200 on news of L success, IMHO of course.